These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8702361)

  • 41. Case study of the anemic patient: epoetin alfa--focus on vascular access.
    Thomas-Hawkins C
    ANNA J; 1995 Feb; 22(1):52-5. PubMed ID: 7598564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Case management of the anemic patient: epoetin alfa--focus on cognitive function.
    Corea AL
    ANNA J; 1993 Jun; 20(3):350-3. PubMed ID: 8352632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Case study of the anemic patient: epoetin alfa--focus on iron management.
    Kirlin LF
    ANNA J; 1995 Apr; 22(2):192-5. PubMed ID: 7786067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anemia management in patients with chronic conditions that affect erythropoiesis. Case study of the anemic patients.
    Deziel SM
    Nephrol Nurs J; 2002 Dec; 29(6):582-5. PubMed ID: 12596607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Administration of Epoetin alfa. Case study of the anemic patient.
    Cutler M
    ANNA J; 1997 Aug; 24(4):459-65; quiz 466. PubMed ID: 9325701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perspectives on the improvement of quality of life with epoetin alfa therapy.
    Lundin AP; Delano BG; Quinn-Cefaro R
    Pharmacotherapy; 1990; 10(2 ( Pt 2)):22S-26S. PubMed ID: 2345708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Erythropoietin therapy in patients with chronic renal failure.
    Pinevich AJ; Petersen J
    West J Med; 1992 Aug; 157(2):154-7. PubMed ID: 1441466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How to design an anemia management protocol.
    Senger JM; Trenkle JA; St John WD
    ANNA J; 1998 Apr; 25(2):235-40. PubMed ID: 9801503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Case management of the anemic patient. Epoetin alfa: focus on sexual dysfunction.
    Fearing MO
    ANNA J; 1992 Dec; 19(6):570-1. PubMed ID: 1292419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Case management of the anemic patient. Epoetin alfa: focus on inflammation and infection.
    Starmann BL
    ANNA J; 1992 Jun; 19(3):280-1. PubMed ID: 1627012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
    Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF
    Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In search of an optimal hematocrit level in dialysis patients: rehabilitation and quality-of-life implications.
    Paganini EP
    Am J Kidney Dis; 1994 Jul; 24(1 Suppl 1):S10-6; discussion S31-2. PubMed ID: 8023833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Case management of the anemic patient: epoetin alfa--focus on iron supplementation.
    Kirlin LF
    ANNA J; 1993 Dec; 20(6):678-81. PubMed ID: 8267412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Case management of the anemic patient: epoetin alfa--focus on compliance.
    Currier H
    ANNA J; 1993 Aug; 20(4):470-3. PubMed ID: 8368881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of epoetin beta in anemic predialysis patients with chronic renal failure.
    Koch KM; Koene RA; Messinger D; Quarder O; Scigalla P
    Clin Nephrol; 1995 Sep; 44(3):201-8. PubMed ID: 8556837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nursing care of predialysis patients receiving epoetin alfa.
    Brown JM
    ANNA J; 1991 Jun; 18(3):306-14. PubMed ID: 2064456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.
    Eschbach JW; Kelly MR; Haley NR; Abels RI; Adamson JW
    N Engl J Med; 1989 Jul; 321(3):158-63. PubMed ID: 2747747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Case management of the anemic patient. Focus on blood pressure and rHuEPO therapy.
    Holechek MJ; Watson AJ
    ANNA J; 1990 Feb; 17(1):72-3. PubMed ID: 2317107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transfusion therapy: associated risks and alternative approaches.
    Picard VT; Sayers MH; Spinowitz BS; Richner RE
    ANNA J; 1990 Dec; 17(6):457-64. PubMed ID: 2256728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case study of the anemic patient: epoetin alfa--focus on exercise.
    Painter P; Carlson L
    ANNA J; 1994 May; 21(3):304-7. PubMed ID: 7998811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.